Philip J. Beale

Philip J. Beale

Hospital Rd
Concord, NSW 2139, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

Journal: Journal of gynecologic oncology

Published: September 19, 2025

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.

Journal: The New England journal of medicine

Published: June 01, 2025

Real-World Outcomes of Patients Treated With Neoadjuvant Imatinib for Locally Advanced, Recurrent and Limited Metastatic Gastrointestinal Stromal Tumour in an Australian Cancer Training Network.

Real-World Outcomes of Patients Treated With Neoadjuvant Imatinib for Locally Advanced, Recurrent and Limited Metastatic Gastrointestinal Stromal Tumour in an Australian Cancer Training Network.

Journal: Asia-Pacific journal of clinical oncology

Published: April 17, 2025

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Journal: Nature communications

Published: December 23, 2024

An Australian mainstream genetic testing program: Clinicians views about current and future practices.

An Australian mainstream genetic testing program: Clinicians views about current and future practices.

Journal: Asia-Pacific journal of clinical oncology

Published: May 29, 2023

Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study.

Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study.

Journal: The Journal of pharmacy and pharmacology

Published: May 03, 2023

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 13, 2023

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

Journal: Journal of gynecologic oncology

Published: March 08, 2023

Stakeholder perspectives on the impact of COVID-19 on oncology services: a qualitative study.

Stakeholder perspectives on the impact of COVID-19 on oncology services: a qualitative study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 24, 2023

Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: a pilot study.

Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: a pilot study.

Journal: Cancer chemotherapy and pharmacology

Published: January 12, 2023

Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial.

Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial.

Journal: Implementation science : IS

Published: January 09, 2023

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).

Journal: Cancers

Published: November 16, 2022

Showing 1-12 of 84

Last Updated: 09/26/2026